Drug Patents owned by Benuvia
1. List of Syndros drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US9345771 | BENUVIA | Oral cannabinoid formulations |
Aug, 2028
(5 years from now) | |
| US8222292 | BENUVIA | Liquid cannabinoid formulations |
Aug, 2028
(5 years from now) | |
| US10265293 | BENUVIA | Oral cannabinoid formulations |
Aug, 2028
(5 years from now) | |
| US11253472 | BENUVIA | Oral cannabinoid formulations |
Aug, 2028
(5 years from now) | |
Drugs and Companies using DRONABINOL ingredient
Market Authorisation Date: 23 March, 2017
Treatment: NA
Dosage: SOLUTION;ORAL
How can I launch a generic of SYNDROS before it's patent expiration?
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic